Skip to main content
Premium Trial:

Request an Annual Quote

David Hoffmeister, Kate Gilbert, Emily Winn-Deen, Sam Rua, and Laurie Keating


David Hoffmeister has become CFO and senior vice president of Invitrogen, succeeding Eric Winzer, the Carlsbad, Calif.-based company said this week. He joins the company from McKinsey, where he was a senior partner. Winzer will remain part of the Invitrogen executive team.

Kate Gilbert has been promoted to director of marketing of Ciphergen Biosystems. She replaces Dick Rubin, who left the company in August. Gilbert was previously consumables product manager at Ciphergen.

Emily Winn-Deen has joined Cepheid of Sunnyvale, Calif., as vice president of strategic planning and business development, the company said last month. Most recently, she led the genomics business group at Roche Molecular Systems in Pleasanton, Calif. In the past, she held appointments at Applied Biosystems, Oncor, and Celera Genomics. Winn-Deen holds a PhD in chemistry from Boston University and a BS in chemistry from Lehigh University.

Sam Rua has become director of regulatory affairs and quality assurance of Third Wave Technologies, the Madison, Wis.-based company said this week. Rua, 44, joins the company from Ventana Medical Systems, where he was director of regulatory affairs. He holds a bachelor’s degree in microbiology from the University of Arizona.

Laurie Keating has become senior vice president, general counsel, and secretary of Millennium Pharmaceuticals, the Cambridge, Mass.-based company said last week. Most recently, she was executive vice president of operations and finance and a member of the board of directors of Hydra Biosciences.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.